國光生 News Releases

【Adimmune Corp.】February 2026 Revenue NT$0.06 Billion (YoY -19.7%)

Adimmune Corporation (4142), a vaccine and biopharmaceutical developer and manufacturer, announced i… · 2026-02-01

[Adimmune] Announcement of Important Resolutions at the 2026 Annual General Meeting

Adimmune Corporation held its annual general meeting on June 4, 2026, approving the business report,… · 2026-06-04

[Adimmune] May 2026 Revenue Reaches NT$6.77 Million (Up 51.9% YoY)

Adimmune Corporation (code: 4142), a biotechnology and medical care company, announced its May 2026 … · 2026-05-01

【Adimmune】March 2026 Revenue NT$65 Million (YoY +2102.7%)

Adimmune's revenue for March 2026 was NT$65 million, a staggering increase of +2102.7% year-over-yea… · 2026-03-01

Adimmune Announces Q1 2026 Consolidated Financial Results

Adimmune Corporation reported its consolidated financial results for the first quarter of 2026 to th… · 2026-05-13

Adimmune Corp. (4142) Reports April 2026 Revenue of NT$23 Million, Up 474.4% YoY

Adimmune Corp. (4142), in the biotechnology and medical industry, announced April 2026 revenue of NT… · 2026-04-01

Adimmune: Announcement of Board Meeting Date for Presentation of Q1 2026 Financial Report

Adimmune announced the board meeting date for the presentation of its first-quarter 2026 financial r… · 2026-05-06

[Adimmune] Announcement of Change in Internal Auditing Officer

Adimmune announced a routine personnel change. The head of internal auditing, Shih Fei-Meng, has bee… · 2026-04-22

[Adimmune] Announcement of the Board of Directors' Resolution to Convene the 115 Annual Shareholders' Meeting (Addition of Report Item)

Adimmune's board resolved to hold the 115 Annual Shareholders' Meeting on June 4, in-person in Taich… · 2026-04-22

【Adimmune】March 2026 Revenue NT$65 Million (YoY +2102.7%)

Adimmune's revenue for March 2026 was NT$65 million, a staggering increase of +2102.7% year-over-yea… · 2026-03-01

【Adimmune Corp.】February 2026 Revenue NT$0.06 Billion (YoY -19.7%)

Adimmune Corporation (4142), a vaccine and biopharmaceutical developer and manufacturer, announced i… · 2026-02-01

[Adimmune] Announcement of the Board of Directors' Resolution to Convene the 115 Annual Shareholders' Meeting (Addition of Report Item)

Adimmune's board resolved to hold the 115 Annual Shareholders' Meeting on June 4, in-person in Taich… · 2026-04-22

[Adimmune] Announcement of Change in Internal Auditing Officer

Adimmune announced a routine personnel change. The head of internal auditing, Shih Fei-Meng, has bee… · 2026-04-22

Adimmune Corp. (4142) Reports April 2026 Revenue of NT$23 Million, Up 474.4% YoY

Adimmune Corp. (4142), in the biotechnology and medical industry, announced April 2026 revenue of NT… · 2026-04-01

Adimmune: Announcement of Board Meeting Date for Presentation of Q1 2026 Financial Report

Adimmune announced the board meeting date for the presentation of its first-quarter 2026 financial r… · 2026-05-06

Adimmune Announces Q1 2026 Consolidated Financial Results

Adimmune Corporation reported its consolidated financial results for the first quarter of 2026 to th… · 2026-05-13